APVO stock forecast for 2023 – 2027
Last updated: April 20, 2024
Are you interested in Aptevo Therapeutics Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the APVO stock price in 2022-2027. Is APVO a good long term stock? When should I take profit in Aptevo Therapeutics stock? Buy or sell stock? Will APVO stock price go up? What are analysts’ forecasts for APVO stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. APVO stock returns are also predicted based on historical data.
According to our research, APVO stock is a awesome long-term investment. APVO share price has been in a bull cycle for the past year. Aptevo Therapeutics Inc. stock trend is positive.
Aptevo Therapeutics company info
| Industry | Biotechnology |
| Address | 2401 4th Avenue, Seattle, WA, 98121, United States |
| Website | https://www.aptevotherapeutics.com |
Forecasting
52 Week High: 14.4733 USD
52 Week Low: 6.04586 USD
1 Year Forecast: 12.58 USD
5 Year Forecast: 43.5997 USD
Agilent Technologies info
Market Cap: 28.21M
52 Week Change: -28.981%
52 Week High: 43.21 USD
52 Week Low: 4.74 USD
Beta: 0.73307
50 Day Moving Average: 7.2
90 Day Moving Average: 8.810
200 Day Moving Average: 13.42
Resistance Level: 5.90886
Pivot Point: 5.88234
Support Level: 5.84766
Enterprise Value: 3,361,510
Forward P/E: -1.28
Forward EPS: -4.23
Profit Margin: -265.80%
Shares Outstanding: 4,898,030
EBITDA: -0.15
Held Percent Institutions: 21.07%
PEG Ratio (5Y): 0
Trailing EPS: -6.6
Aptevo Therapeutics stock forecasts for 2023-2027
| Date | Open Price | Close Price | Change |
Aptevo Therapeutics Stock Forecast for 2023 | |||
| January 2023 | 11.76 | 15 | 27.55% |
| February 2023 | 16.32 | 16 | -1.96% |
| March 2023 | 16.32 | 15.3 | -6.25% |
| April 2023 | 15.3 | 15.3 | 0% |
| May 2023 | 16.16 | 15.84 | -1.98% |
| June 2023 | 16 | 15.68 | -2% |
| July 2023 | 15.84 | 15.84 | 0% |
| August 2023 | 17 | 17.34 | 2% |
| September 2023 | 15.68 | 16.16 | 3.06% |
| October 2023 | 15.84 | 17 | 7.32% |
| November 2023 | 16.83 | 21.78 | 29.41% |
| December 2023 | 22.44 | 20.2 | -9.98% |
Aptevo Therapeutics Stock Forecast for 2024 | |||
| January 2024 | 20.2 | 22.54 | 11.58% |
| February 2024 | 23.23 | 23.46 | 0.99% |
| March 2024 | 23 | 22.54 | -2% |
| April 2024 | 23 | 24.48 | 6.43% |
| May 2024 | 23.76 | 23.52 | -1.01% |
| June 2024 | 23.76 | 23.76 | 0% |
| July 2024 | 23.76 | 24.24 | 2.02% |
| August 2024 | 24.24 | 24.24 | 0% |
| September 2024 | 24 | 23.76 | -1% |
| October 2024 | 24.24 | 25.5 | 5.2% |
| November 2024 | 25.5 | 29.4 | 15.29% |
| December 2024 | 30.3 | 28.28 | -6.67% |
Aptevo Therapeutics Stock Forecast for 2025 | |||
| January 2025 | 28 | 31.31 | 11.82% |
| February 2025 | 31.36 | 30.69 | -2.14% |
| March 2025 | 30.38 | 31 | 2.04% |
| April 2025 | 31.31 | 30.69 | -1.98% |
| May 2025 | 31.62 | 31.36 | -0.82% |
| June 2025 | 32.32 | 32.64 | 0.99% |
| July 2025 | 32.64 | 32.64 | 0% |
| August 2025 | 32 | 32.64 | 2% |
| September 2025 | 31.36 | 31.36 | 0% |
| October 2025 | 32.32 | 32.67 | 1.08% |
| November 2025 | 34.34 | 37.62 | 9.55% |
| December 2025 | 37.62 | 36 | -4.31% |
Aptevo Therapeutics Stock Forecast for 2026 | |||
| January 2026 | 35.64 | 39.78 | 11.62% |
| February 2026 | 39.78 | 39.39 | -0.98% |
| March 2026 | 38.22 | 38.22 | 0% |
| April 2026 | 39.39 | 38.22 | -2.97% |
| May 2026 | 39.39 | 39.6 | 0.53% |
| June 2026 | 39.2 | 40 | 2.04% |
| July 2026 | 40.4 | 40.8 | 0.99% |
| August 2026 | 40.4 | 40.8 | 0.99% |
| September 2026 | 39.6 | 40.4 | 2.02% |
| October 2026 | 40.4 | 39.6 | -1.98% |
| November 2026 | 41 | 46.92 | 14.44% |
| December 2026 | 46.46 | 43.12 | -7.19% |
Aptevo Therapeutics Stock Forecast for 2027 | |||
| January 2027 | 43.12 | 44.1 | 2.27% |